Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) hit a new 52-week high on Monday . The company traded as high as $8.97 and last traded at $8.54, with a volume of 40243 shares. The stock had previously closed at $8.40.
Shionogi & Co., Ltd. Trading Down 1.4%
The company has a market capitalization of $14.51 billion, a P/E ratio of 14.30, a price-to-earnings-growth ratio of 2.37 and a beta of 0.18. The company has a debt-to-equity ratio of 0.01, a current ratio of 7.64 and a quick ratio of 7.01. The firm has a fifty day moving average price of $8.11 and a 200-day moving average price of $7.55.
Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.03). The company had revenue of $721.77 million during the quarter, compared to the consensus estimate of $824.23 million. Shionogi & Co., Ltd. had a return on equity of 12.02% and a net margin of 35.53%. On average, equities research analysts anticipate that Shionogi & Co., Ltd. will post 0.66 earnings per share for the current year.
Shionogi & Co., Ltd. Company Profile
(
Get Free Report)
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
See Also
Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.
While Shionogi & Co., Ltd. Unsponsored ADR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
